Delivery Order SPE2DB22D3004-SPE2DB24FPJ76
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a potential value of $3,581.40. The contract has a period of performance through February 26, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., has been awarded a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a potential value of $1,343.96. The award does not have a set-aside designation. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,163.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, to support military treatment programs and facilities. The delivery order has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,807.64 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a completion date of July 12, 2023. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,231.42 to provide PROCTOFOAM-HC 1%-1% FOAM 10GM. The contract has a completion date of February 22, 2024 and was awarded on February 21, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract, valued at $1,735.56, is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has an ultimate completion date of March 22, 2024. Amerisourcebergen Drug Corp has also been awarded an indefinite delivery contract (IDC) by DLA with a...
- Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, has been awarded a $4,698.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $4,078.38 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide PROCTOFOAM 10GM 1S, a pharmaceutical product. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184900 - PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The $1,215.60 award has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,156.42 to Amerisourcebergen Drug Corp's Corporate Office division for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPJ76Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc., was awarded a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a potential value of $2,963.80. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and will deliver the pharmaceutical product to the DLA Troop Support Medical program, which supports the Department of Defense. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, awarded solely to Amerisourcebergen Drug Corp. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 2/20/24 |